Almost all of the requirements to identify where the goods are going and allow the identification and tracking of the goods would be eliminated from the bill. There would be the remaining requirement to post some information on a website. On top of that, enforcement mechanisms in CAMR now would allow if drugs were diverted back to Canada or sent to countries besides countries in the developing world.
There would be no mechanisms by either the government or the Commissioner of Patents to withdraw the licence, challenge it, or say we think these are being used for commercial purposes. The patent holder might not even be aware, in some instances, of what was going where. If they did become aware, there would be no mechanism for them to apply to the Federal Court to say, “These are actually being used for commercial reasons, not humanitarian reasons.”